# Nutrition Drinks Alongside a GLP-1

By Ruth Calder, Enforcement Editor (https://glpwatchdog.org/authors/ruth-calder) | Published: 2026-08-19 | Updated: 2026-10-27

Canonical page: https://glpwatchdog.org/research/nutrition-drinks-alongside-a-glp1

> A real-world study associated nutrition drinks with more fat loss and a better fat-to-lean ratio. The strongest effects were among people who complied, which is a compliance finding wearing a product's clothes.

## Key points

- ONS use associated with −10.1 lb weight and −8.4 lb fat, ratio favorable at 2.3.
- The effect was strongest among 'compliers'. People who reliably take a supplement reliably do everything else.
- The mechanism on offer is protein and micronutrients. Food supplies both.
- Apply the same scrutiny to a supplement claim as to a drug claim.

Oral nutritional supplements, the protein-and-micronutrient drinks sold in every pharmacy, are increasingly marketed to people on GLP-1 drugs. A real-world study found their users lost more weight and more fat, with a better fat-to-lean ratio.[1] The strongest effects appeared among **compliers**, and that word is doing more work than the product is.

## What was observed

*Associations with oral nutritional supplement use during GLP-1 therapy. Observational.*

| Measure | Difference associated with ONS use |
| --- | --- |
| BMI | −1.4 kg/m² |
| Body fat | −8.4 lb |
| Total weight | −10.1 lb |
| Body fat ratio | −2 percentage points |
| Lean body mass | −5.5 lb (also lost) |
| Fat-to-lean loss ratio | 2.3 (favorable) |

Effects were strongest among people under 50, those who complied with the supplement, those treated for 181 to 365 days, and those without diabetes.[1]

## Why the compliance subgroup is the tell

“The effect was strongest among people who actually took the supplement” sounds like a demonstration that the supplement works. It is at least as consistent with something duller: people who reliably take a supplement are people who reliably do things.

> Compliance is a personality trait before it is a product outcome.

Someone who is prescribed nutritional drinks, remembers them daily, and keeps it up for months is also more likely to attend appointments, fill prescriptions on time, escalate their dose on schedule, and exercise. Every one of those independently predicts better results. Dose escalation in particular, which we found [most people never complete](https://glpwatchdog.org/research/most-people-never-reach-the-dose), is a large determinant of outcome on its own.

This is an observational comparison from a single clinic’s records: of 252 patients, 88 who were prescribed the drinks were matched with 32 who were not.[1] The drinks were prescribed only to people diagnosed with protein malnutrition, so the two groups differed before treatment began. The authors note that matching may not fully balance nutritional status between them, and no statistical adjustment fully removes a difference like that.

> **Apply the same scrutiny you would to a drug claim.** A supplement finding tends to get an easier ride than a pharmaceutical one, and it should not. This study was funded by Abbott, which makes nutrition drinks, and three of its eight authors are Abbott employees and stockholders; the paper states that the funder had no role in the analysis.[1] The commercial incentive to publish a positive result exists in both industries, and the study designs available to supplements are usually weaker.

## What is plausibly real underneath it

There may well be something here, and it is not exotic. These drinks deliver protein and micronutrients in a form that requires no appetite, no cooking and no chewing, which is a real advantage when a drug has removed the desire to eat.

The targets themselves are established: at least 1.2 g of protein per kilogram daily, and a panel of micronutrients worth monitoring, both covered in [protein targets and the lab panel](https://glpwatchdog.org/research/protein-targets-and-the-lab-panel). A drink that helps someone reach those is doing something useful. So is chicken.

- **The mechanism on offer is protein and micronutrients**, not a property of the format.
- **Food does the same job** and costs less, for anyone who can manage it.
- **The case for a drink is practical:** low appetite, nausea, or no time, which are the conditions where liquid beats a plate.
- **The intervention with randomized support is resistance training**, covered in [lean mass, drug versus dieting](https://glpwatchdog.org/research/lean-mass-drug-versus-dieting). No supplement has that behind it.

## Frequently asked questions

### Do nutrition drinks help on a GLP-1?

A real-world study associated their use with more weight and fat loss and a better fat-to-lean ratio. It compared patients prescribed the drinks for diagnosed protein malnutrition against patients who were not, at a single clinic. That is not a random difference, so the association is weaker evidence than it looks.

### Why does the 'compliers' finding matter?

Because people who reliably take a supplement are people who reliably do things: attend appointments, fill prescriptions, escalate their dose on schedule. All of those independently predict better outcomes, and dose escalation especially.

### Is there anything useful here?

Probably. These drinks deliver protein and micronutrients without requiring appetite, cooking or chewing, which is a real advantage when a drug has removed the desire to eat. The mechanism is the nutrition, not the format.

### Could I just eat food instead?

Yes, and it costs less. The case for a drink is practical rather than nutritional: low appetite, nausea or no time. If you can meet the protein and micronutrient targets from food, there is no established advantage to buying a supplement.

### What preserves muscle?

Resistance training, which is the only intervention with randomized evidence behind it for changing the proportion of weight lost as lean mass. No nutritional supplement has that support.

## References

1. Hong K, Sulo S, Wang W, et al. Oral Nutritional Supplements and Body Composition Outcomes Among GLP-1 Receptor Agonist Users: Real-World Evidence. Diabetes, Metabolic Syndrome and Obesity. 2026. PMID: 42117035. https://pubmed.ncbi.nlm.nih.gov/42117035/

---

Cite as: GLP Watchdog, Ruth Calder, "Nutrition Drinks Alongside a GLP-1", published 2026-08-19, updated 2026-10-27. https://glpwatchdog.org/research/nutrition-drinks-alongside-a-glp1

Canonical HTML page: https://glpwatchdog.org/research/nutrition-drinks-alongside-a-glp1

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.
